🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06783933
Active, not recruiting Observational

Artificial Intelligence-assisted Diagnosis

NCT06783933 · tracked via the Priya Life Science China tracker
Sponsor
China National Center for Cardiovascular Diseases
Phase
Observational
Started
2025-01-15
Last updated
2025-07-14

Condition(s) studied

Congenital Heart Disease (CHD)Structural Heart Disease

Investigational drug(s) / intervention(s)

surgical or interventional validation

surgical or interventional validation: surgical or interventional validation

Study summary

This study aims to investigate whether an AI-assisted decision support can improve the diagnosis of congenital heart diseases on Chest X-ray.

Eligibility

Sex
ALL
Min age
Max age
Healthy volunteers
Accepted
Inclusion Criteria: 1. Chest X-ray of patients with ASD; 2. Chest X-ray of patients with VSD; 3. Chest X-ray of patients with PDA; 4. Chest X-ray of patients with PFO; 5. Chest X-ray of patients with PS; 6. Chest X-ray of patients with TOF/PAA; 7. Chest X-ray of patients with MS; 8. Chest X-ray of patients with other heart diseases; Exclusion Criteria: 1. CHD Patients without surgical, interventional validation; 2. Serious Scoliosis; 3. Pulmonary inflammation or consolidation

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Fuwai hospital Beijing Beijing Municipality

More China National Center for Cardiovascular Diseases trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06783933 on ClinicalTrials.gov ↗ ← All trials in China